Our Team
Executive Team
Operating Partners and Advisors
Portfolio Company Leadership
Mark W. Womack
Mark W. Womack
CEO, BioCina
Cyrus K. Mirsaidi
Cyrus K. Mirsaidi
CEO, Bridgewest Perth Pharma, LumaCina, NovaCina
Brett Alderson
Brett Alderson
President, Novacina / COO, BridgeWest Perth Pharma
Jonathan Kafer
Jonathan Kafer
President, LumaCina / Chief Commercial Officer, Bridgewest Perth Pharma
Jay Short
Dr. Jay Short
CEO, BioAtla
Andrew Sims
Andrew Sims
CEO, SuiteFiles
Mark Orttung
Mark Orttung
CEO, Projectworks
Matt Hayter
Matt Hayter
President, Projectworks
Andy Lin
Andy Lin
CEO, Provoke Solutions
Laurence Cooper
Dr. Laurence Cooper
Executive Chairman, BIO4T2
Omid Tahernia
Omid Tahernia
Advisor, Bridgewest Group, Endura Technologies
Saba Samiei
Saba Samiei
CEO, MACSO
Nataša Zec
Nataša Zec
CEO, Pontis Technology
Jasna Rakonjac
Dr. Jasna Rakonjac
President, Nanophage Technologies
Sean Feast
Dr. Sean Feast
CEO, PRECISION CHROMATOGRAPHY LIMITED
Nandoun Abeysekera
Dr. Nandoun Abeysekera
CEO, Avasa
Carissa Fonseca
Dr. Carissa Fonseca
CEO, TheiaNova Ltd.
Julie Jones
Julie Jones
CEO, BioValeo Ltd.
Sarah Heine
Sarah Heine
CEO, Zealafoam
Maher Khaled
Maher Khaled
CEO, Luminoma
Associates